5S93 | pdb_00005s93

PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z198194396 synthetic derivative


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.19 Å
  • R-Value Free: 
    0.216 (Depositor), 0.260 (DCC) 
  • R-Value Work: 
    0.189 (Depositor), 0.250 (DCC) 
  • R-Value Observed: 
    0.191 (Depositor) 

wwPDB Validation   3D Report Full Report


This is version 1.2 of the entry. See complete history


Literature

Binding-Site Purification of Actives (B-SPA) Enables Efficient Large-Scale Progression of Fragment Hits by Combining Multi-Step Array Synthesis With HT Crystallography.

Grosjean, H.Aimon, A.Hassell-Hart, S.Thompson, W.Koekemoer, L.Bennett, J.Bradley, A.Anderson, C.Wild, C.Bradshaw, W.J.FitzGerald, E.A.Krojer, T.Fedorov, O.Biggin, P.C.Spencer, J.von Delft, F.

(2025) Angew Chem Int Ed Engl 64: e202424373-e202424373

  • DOI: https://doi.org/10.1002/anie.202424373
  • Primary Citation of Related Structures:  
    5S8R, 5S8S, 5S8T, 5S8U, 5S8V, 5S8W, 5S8X, 5S8Y, 5S8Z, 5S90, 5S91, 5S92, 5S93, 5S94, 5S95, 5S96, 5S97, 5S98, 5S99, 5S9A, 5S9B, 5S9C, 5S9D, 5S9E, 5S9G, 5S9J

  • PubMed Abstract: 

    Fragment approaches are long-established in target-based ligand discovery, yet their full transformative potential lies dormant because progressing the initial weakly binding hits to potency remains a formidable challenge. The only credible progression paradigm involves multiple cycles of costly conventional design-make-test-analyse medicinal chemistry. We propose an alternative approach to fragment elaboration, namely performing large numbers of parallel and diverse automated multiple step reactions, and evaluating the binding of the crude reaction products by high-throughput protein X-ray crystallography. We show it is effective and low-cost to perform, in parallel, large numbers of non-uniform multi-step reactions, because, even without compound purification, crystallography provides a high-quality readout of binding. This can detect low-level binding of weakly active compounds, which the target binding site extracts directly from crude reaction mixtures. In this proof-of-concept study, we have expanded a fragment hit, from a crystal-based screen of the second bromodomain of pleckstrin homology domain-interacting protein (PHIP(2)), using array synthesis on low-cost robotics. We were able to implement 6 independent multi-step reaction routes of up to 5 steps, attempting the synthesis of 1876 diverse expansions, designs entirely driven by synthetic tractability. The expected product was present in 1108 (59%) crude reaction mixtures, detected by liquid chromatography mass spectrometry (LCMS). 22 individual products were resolved in the crystal structures of crude reaction mixtures added to crystals, providing an initial structure activity relationship map. 19 of these showed binding pose stability, while, through binding instability in the remaining 3 products, we could resolve a stereochemical preference for mixtures containing racemic compounds. One compound showed biochemical potency (IC 50 =34 μM) and affinity (K d =50 μM) after resynthesis. This approach therefore lends itself to routine fragment progression, if coupled with algorithmically guided compound and reaction design and new formalisms for data analysis.


  • Organizational Affiliation
    • Diamond Light Source Ltd, Harwell Science and Innovation Campus, OX11 0QX, Didcot, UK.

Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
PH-interacting protein149Homo sapiensMutation(s): 0 
Gene Names: PHIPDCAF14WDR11
UniProt & NIH Common Fund Data Resources
Find proteins for Q8WWQ0 (Homo sapiens)
Explore Q8WWQ0 
Go to UniProtKB:  Q8WWQ0
PHAROS:  Q8WWQ0
GTEx:  ENSG00000146247 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ8WWQ0
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
Y2J
Query on Y2J

Download Ideal Coordinates CCD File 
B [auth A]4-(5-chlorofuran-2-carbonyl)-N-(2-methoxyethyl)piperazine-1-carboxamide
C13 H18 Cl N3 O4
VHIWNIAUJINVEH-UHFFFAOYSA-N
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.19 Å
  • R-Value Free:  0.216 (Depositor), 0.260 (DCC) 
  • R-Value Work:  0.189 (Depositor), 0.250 (DCC) 
  • R-Value Observed: 0.191 (Depositor) 
Space Group: C 1 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 81.848α = 90
b = 26.939β = 99.9
c = 55.551γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
Aimlessdata scaling
PDB_EXTRACTdata extraction
XDSdata reduction
REFMACphasing

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2021-02-17
    Type: Initial release
  • Version 1.1: 2024-03-06
    Changes: Data collection, Database references
  • Version 1.2: 2026-01-21
    Changes: Database references, Structure summary